Kedokteran & Kesehatan editorial
Open AccessOA2022
The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas
A study of 17 American countries found that none have established national public health policies specifically for NAFLD, despite its high prevalence and associated morbidity. The authors call for urgent implementation of policies to reduce the burden.
L. Díaz; Eduardo Fuentes-López; G. Ayares; F. Idalsoaga; J. Arnold; Andrea Márquez-Lomas; C. Ramírez; María Paz Medel; Francisca Viñuela; Lucas Lacalle; J. Roblero; C. Ferreccio; M. Lazo; M. Brahmania; A. Singal; M. Dirchwolf; N. Méndez-Sánchez; N. Chávez-Tapia; Patricia Guerra; J. Restrepo; C. Oliveira; J. Lombardo; Abel Sánchez; M. Elizondo; M. Tagle; Martín Padilla; M. Sánchez; E. Carrera; M. Girala; O. Chéry; M. Castellanos-Fernández; F. Barrera; J. Lazarus; P. Kamath; R. Bataller; M. Arrese; J. Arab· The Lancet Gastroenterology and Hepatology· 2022· DOI 10.1016/s2468-1253(22)00008-5
The core problem
Non-alcoholic fatty liver disease (NAFLD) affects 20-25% of the general population and is associated with morbidity, increased mortality, and elevated health-care costs. Most NAFLD risk factors are modifiable and, therefore, potentially amenable to being reduced by public health policies. To date, there is no information about NAFLD-related public health policies in the Americas. This study aimed to analyze data from 17 American countries to assess the existence of national public health policies targeting NAFLD and related conditions.
Innovation
The authors conducted a cross-sectional analysis of data from 17 American countries. They collected information on the existence of national public health policies related to NAFLD and its risk factors, including diabetes, hypertension, cardiovascular diseases, obesity, and dyslipidaemia. Additionally, they assessed the presence of registries for NAFLD burden and efforts to raise awareness. Data were obtained from official sources and key informants in each country.
Introduction
Non-alcoholic fatty liver disease (NAFLD) affects 20-25% of the general population and is associated with morbidity, increased mortality, and elevated health-care costs. Most NAFLD risk factors are modifiable and, therefore, potentially amenable to being reduced by public health policies. To date, there is no information about NAFLD-related public health policies in the Americas. This study aimed to analyze data from 17 American countries to assess the existence of national public health policies targeting NAFLD and related conditions.
Why it matters
The findings highlight a critical gap in public health policy across the Americas: despite the high prevalence of NAFLD and its associated morbidity and mortality, no country has implemented a national policy specifically targeting NAFLD. The heterogeneity in policies for related conditions suggests that some countries have stronger frameworks for metabolic and cardiovascular diseases, but these are not sufficient to address NAFLD comprehensively. The lack of registries and awareness efforts further exacerbates the problem. The authors emphasize the urgent need for the implementation of public health policies to decrease the burden of NAFLD in the Americas. Such policies should include prevention strategies targeting modifiable risk factors, surveillance systems, and awareness campaigns.
Who should read this
Pembaca Research Digest dan praktisi rumpun ini.
Opening member content…